Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12615000488505Phase 4Completed
Phase 4, open-label trial of ketorolac, epinephrine and ropivacaine in postoperative pain and osteoarthritis (OA), sponsored by Fremantle Hospital. Primary endpoints: Opioid consumption during first 24 hours postoperative, Total inpatient opioid consumption and 1 more. Started Oct 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12615000488505.